0 XP   0   0   0

CHEMO PHARMA LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell CHEMO PHARMA LABORATORIES LTD.?

I guess you are interested in CHEMO PHARMA LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse CHEMO PHARMA LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of CHEMO PHARMA LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is CHEMO PHARMA LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how CHEMO PHARMA LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value CHEMO PHARMA LABORATORIES LTD.. The closing price on 2023-01-27 was INR39.50 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
CHEMO PHARMA LABORATORIES LTD. Daily Candlestick Chart
CHEMO PHARMA LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of CHEMO PHARMA LABORATORIES LTD.




Current price per share

INR39.50

2. Growth of CHEMO PHARMA LABORATORIES LTD.




Is CHEMO PHARMA LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4m$1.3m$68.8k4.8%

How much money is CHEMO PHARMA LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$68.8k$30.7k$38.1k55.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of CHEMO PHARMA LABORATORIES LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of CHEMO PHARMA LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit CHEMO PHARMA LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • A Net Profit Margin of 0.0% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient CHEMO PHARMA LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • 4.8% Return on Assets means that CHEMO PHARMA LABORATORIES LTD. generated ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 4.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY2.3%+2.5%
TTM4.8%5Y3.2%+1.6%
5Y3.2%10Y3.2%0.0%
1.1.3. Return on Equity

Shows how efficient CHEMO PHARMA LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • 4.8% Return on Equity means CHEMO PHARMA LABORATORIES LTD. generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 4.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY2.3%+2.6%
TTM4.8%5Y3.2%+1.6%
5Y3.2%10Y3.2%0.0%

1.2. Operating Efficiency of CHEMO PHARMA LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient CHEMO PHARMA LABORATORIES LTD. is operating .

  • Measures how much profit CHEMO PHARMA LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient CHEMO PHARMA LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are ₹0.00 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

1.3. Liquidity of CHEMO PHARMA LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if CHEMO PHARMA LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 58.17 means the company has ₹58.17 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 58.171. The company is very able to pay all its short-term debts. +2
  • The TTM is 58.171. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ58.171TTM58.1710.000
TTM58.171YOY187.533-129.361
TTM58.1715Y94.854-36.682
5Y94.85410Y94.8540.000
1.3.2. Quick Ratio

Measures if CHEMO PHARMA LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • A Quick Ratio of 50.81 means the company can pay off ₹50.81 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 50.806. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 50.806. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ50.806TTM50.8060.000
TTM50.806YOY-+50.806
TTM50.8065Y27.739+23.067
5Y27.73910Y27.7390.000

1.4. Solvency of CHEMO PHARMA LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of CHEMO PHARMA LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.01 means that CHEMO PHARMA LABORATORIES LTD. assets are financed with 0.9% credit (debt) and the remaining percentage (100% - 0.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 0.009. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.009. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.009TTM0.0090.000
TTM0.009YOY0.005+0.004
TTM0.0095Y0.011-0.002
5Y0.01110Y0.0110.000
1.4.2. Debt to Equity Ratio

Measures if CHEMO PHARMA LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 0.9% means that company has ₹0.01 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 0.009. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.009. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.009TTM0.0090.000
TTM0.009YOY0.005+0.004
TTM0.0095Y0.011-0.002
5Y0.01110Y0.0110.000

2. Market Valuation of CHEMO PHARMA LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings CHEMO PHARMA LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare CHEMO PHARMA LABORATORIES LTD. to the  industry mean.
  • A PE ratio of 11.06 means the investor is paying ₹11.06 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The EOD is 10.582. Very good. +2
  • The MRQ is 11.064. Very good. +2
  • The TTM is 11.064. Very good. +2
Trends
Current periodCompared to+/- 
EOD10.582MRQ11.064-0.482
MRQ11.064TTM11.0640.000
TTM11.064YOY10.707+0.357
TTM11.0645Y7.957+3.107
5Y7.95710Y7.9570.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of CHEMO PHARMA LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The MRQ is 4.941. Seems overpriced? -1
  • The TTM is 4.941. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ4.941TTM4.9410.000
TTM4.941YOY17.775-12.834
TTM4.9415Y7.961-3.020
5Y7.96110Y7.9610.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of CHEMO PHARMA LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.54 means the investor is paying ₹0.54 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of CHEMO PHARMA LABORATORIES LTD.:

  • The EOD is 0.513. Very good. +2
  • The MRQ is 0.536. Very good. +2
  • The TTM is 0.536. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.513MRQ0.536-0.023
MRQ0.536TTM0.5360.000
TTM0.536YOY0.244+0.293
TTM0.5365Y0.256+0.280
5Y0.25610Y0.2560.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CHEMO PHARMA LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.7333.7330%1.667+124%19.258-81%19.258-81%
Book Value Growth--1.0511.0510%1.023+3%1.038+1%1.038+1%
Book Value Per Share--77.03177.0310%73.299+5%72.706+6%72.706+6%
Book Value Per Share Growth--1.0511.0510%1.023+3%1.038+1%1.038+1%
Current Ratio--58.17158.1710%187.533-69%94.854-39%94.854-39%
Debt To Asset Ratio--0.0090.0090%0.005+76%0.011-15%0.011-15%
Debt To Equity Ratio--0.0090.0090%0.005+76%0.011-15%0.011-15%
Dividend Per Share----0%-0%-0%-0%
Eps--3.7333.7330%1.667+124%2.386+56%2.386+56%
Eps Growth--2.2392.2390%0.602+272%1.618+38%1.618+38%
Free Cash Flow Per Share---2.191-2.1910%10.323-121%8.733-125%8.733-125%
Free Cash Flow Per Share Growth---0.212-0.2120%0.320-166%2.686-108%2.686-108%
Free Cash Flow To Equity Per Share---2.191-2.1910%10.323-121%8.733-125%8.733-125%
Free Cash Flow To Equity Per Share Growth---0.212-0.2120%0.320-166%2.686-108%2.686-108%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.513-5%0.5360.5360%0.244+120%0.256+109%0.256+109%
Pe Ratio10.582-5%11.06411.0640%10.707+3%7.957+39%7.957+39%
Peg Ratio--4.9414.9410%17.775-72%7.961-38%7.961-38%
Price Per Share39.500-5%41.30041.3000%17.850+131%19.063+117%19.063+117%
Price To Total Gains Ratio10.582-5%11.06411.0640%10.707+3%6.068+82%6.068+82%
Profit Growth--2.2392.2390%0.602+272%1.618+38%1.618+38%
Quick Ratio--50.80650.8060%-+100%27.739+83%27.739+83%
Return On Assets--0.0480.0480%0.023+112%0.032+50%0.032+50%
Return On Equity--0.0480.0480%0.023+113%0.032+49%0.032+49%
Total Gains Per Share--3.7333.7330%1.667+124%19.258-81%19.258-81%
Total Gains Per Share Growth--2.2392.2390%0.602+272%0.961+133%0.961+133%
Usd Book Value--1421230.3631421230.3630%1352358.063+5%1341430.669+6%1341430.669+6%
Usd Book Value Change Per Share--0.0460.0460%0.021+124%0.237-81%0.237-81%
Usd Book Value Per Share--0.9470.9470%0.902+5%0.894+6%0.894+6%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0460.0460%0.021+124%0.029+56%0.029+56%
Usd Free Cash Flow---40414.762-40414.7620%190455.402-121%161125.464-125%161125.464-125%
Usd Free Cash Flow Per Share---0.027-0.0270%0.127-121%0.107-125%0.107-125%
Usd Free Cash Flow To Equity Per Share---0.027-0.0270%0.127-121%0.107-125%0.107-125%
Usd Price Per Share0.486-5%0.5080.5080%0.220+131%0.234+117%0.234+117%
Usd Profit--68872.30068872.3000%30758.918+124%44017.244+56%44017.244+56%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.0460.0460%0.021+124%0.237-81%0.237-81%
 EOD+3 -2MRQTTM+0 -0YOY+21 -135Y+19 -1510Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of CHEMO PHARMA LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.582
Price to Book Ratio (EOD)Between0-10.513
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than150.806
Current Ratio (MRQ)Greater than158.171
Debt to Asset Ratio (MRQ)Less than10.009
Debt to Equity Ratio (MRQ)Less than10.009
Return on Equity (MRQ)Greater than0.150.048
Return on Assets (MRQ)Greater than0.050.048
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of CHEMO PHARMA LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose39.500
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets116,630
Total Liabilities1,083
Total Stockholder Equity115,547
 As reported
Total Liabilities 1,083
Total Stockholder Equity+ 115,547
Total Assets = 116,630

Assets

Total Assets116,630
Total Current Assets62,973
Long-term Assets62,973
Total Current Assets
Cash And Cash Equivalents 6,859
Short-term Investments 55,000
Total Current Assets  (as reported)62,973
Total Current Assets  (calculated)61,859
+/- 1,114
Long-term Assets
Long-term Assets  (as reported)53,657
Long-term Assets  (calculated)0
+/- 53,657

Liabilities & Shareholders' Equity

Total Current Liabilities1,083
Long-term Liabilities0
Total Stockholder Equity115,547
Total Current Liabilities
Total Current Liabilities  (as reported)1,083
Total Current Liabilities  (calculated)0
+/- 1,083
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings 49,132
Total Stockholder Equity (as reported)115,547
Total Stockholder Equity (calculated)49,132
+/- 66,415
Other
Capital Stock15,000
Common Stock Shares Outstanding 1,500
Net Invested Capital 115,547
Net Working Capital 61,891



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
104,210
109,657
110,532
116,630
116,630110,532109,657104,21000
   > Total Current Assets 
91,239
85,472
85,393
89,105
109,603
62,973
62,973109,60389,10585,39385,47291,239
       Cash And Cash Equivalents 
0
0
4,662
88,084
108,711
6,859
6,859108,71188,0844,66200
       Short-term Investments 
0
0
0
0
0
55,000
55,00000000
       Net Receivables 
22,505
8,835
55,000
0
0
0
00055,0008,83522,505
       Other Current Assets 
0
0
732
1,021
892
0
08921,02173200
   > Long-term Assets 
0
0
18,817
20,552
929
53,657
53,65792920,55218,81700
       Property Plant Equipment 
94
21
30
748
0
0
00748302194
> Total Liabilities 
0
0
914
2,210
584
1,083
1,0835842,21091400
   > Total Current Liabilities 
5,767
1,332
914
2,210
584
1,083
1,0835842,2109141,3325,767
       Other Current Liabilities 
5,767
1,332
914
2,210
81
0
0812,2109141,3325,767
   > Long-term Liabilities 
0
0
0
0
0
0
000000
> Total Stockholder Equity
0
0
103,296
107,447
109,948
115,547
115,547109,948107,447103,29600
   Retained Earnings 
33,812
34,818
36,881
41,032
43,533
49,132
49,13243,53341,03236,88134,81833,812
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-4,238
Operating Income-4,238-4,238
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,283
Selling And Marketing Expenses-
Operating Expense4,2381,283
 
Net Interest Income (+$)
Interest Income4,746
Interest Expense-0
Net Interest Income4,7444,746
 
Pretax Income (+$)
Operating Income-4,238
Net Interest Income4,744
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,649-4,238
EBIT - interestExpense = 0
5,599
5,599
Interest Expense0
Earnings Before Interest and Taxes (ebit)-3,649
Earnings Before Interest and Taxes (ebitda)3,838
 
After tax Income (+$)
Income Before Tax3,649
Tax Provision--1,950
Net Income From Continuing Ops5,5995,599
Net Income5,599
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--4,744
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
2 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
2 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
2 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart